All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F16%3A00088845" target="_blank" >RIV/00216224:14310/16:00088845 - isvavai.cz</a>

  • Alternative codes found

    RIV/65269705:_____/16:00066238

  • Result on the web

    <a href="http://onlinelibrary.wiley.com/doi/10.1111/bjh.13848/epdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/bjh.13848/epdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/bjh.13848" target="_blank" >10.1111/bjh.13848</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells

  • Original language description

    Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in the Western world. This lymphoproliferative disorder is defined by the presence of at least 5 9 106 clonal lymphocytes/ml peripheral blood (Hallek,2015). The biggest clinical challenge is the fact that CLL eradication by any available therapy, apart from allogeneic stem cell transplantation, fails to cure the disease, inducing only temporary disease remission, i.e., when the disease does not manifest clinically but CLL cells still persist in the body. During this phase a population of CLL cells often slowly re-expands to trigger CLL relapse. The relapse is often based on the poorly understood but clinically important process of therapy-driven selection of more aggressive CLL subclones (Malcikova et al, 2015).

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NV15-29793A" target="_blank" >NV15-29793A: Analysis of WNT/PCP pathway for better management of chronic lymphocytic leukemia</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    British Journal of Haematology

  • ISSN

    0007-1048

  • e-ISSN

  • Volume of the periodical

    175

  • Issue of the periodical within the volume

    2

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    4

  • Pages from-to

    339-342

  • UT code for WoS article

    000385763400019

  • EID of the result in the Scopus database